当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › Nature Reviews Clinical Oncology杂志
Nature Reviews Clinical Oncology
基本信息
期刊名称 Nature Reviews Clinical Oncology
NAT REV CLIN ONCOL
期刊ISSN 1759-4774
期刊官方网站 http://www.nature.com/nrclinonc/index.html
是否OA
出版商 Nature Publishing Group
出版周期 Monthly
始发年份 2009
年文章数 42
最新影响因子 78.8(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学1区 ONCOLOGY 肿瘤学1区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 8.04 9.468 5.017
Medicine
Oncology
11 / 321 96%
补充信息
自引率 1.10%
H-index 108
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1759-4774%5BISSN%5D
投稿指南
期刊投稿网址 http://mts-nrclinonc.nature.com/cgi-bin/main.plex
收稿范围

Nature Reviews Clinical Oncology的文章由国际知名的临床学者和研究人员撰写,针对研究生及更高的医学读者。虽然该期刊面向执业医师,但我们的目的是向从事任何医学学科的读者提供论文。 

期刊收录研究方向:化疗,临床药理学,诊断,流行病学,实验治疗,遗传学,卫生服务、经济和成果研究,血液,激素疗法,成像,免疫疗法,医学肿瘤学,姑息治疗,病理学,儿科肿瘤学,预防,放射治疗,拍摄,信号转导,统计数据,肿瘤外科,靶向治疗

收录体裁
Review, Perspective, News & Views articles, Research Highlights
投稿指南 https://www.nature.com/nrclinonc/for-authors
投稿模板
参考文献格式 https://www.nature.com/nrclinonc/for-authors/preparing-your-submission
编辑信息

Chief Editor: Diana Romero, BSc, PhD ORCiD

Diana obtained her PhD in Biochemistry from the Universidad Autonoma de Madrid (Spain), where she studied the role of TGF-β in cancer progression in Miguel Quintanilla's group. She joined Calvin Vary's laboratory at Maine Medical Center Research Institute (US) for her first postdoctoral project, which was related to TGF-β receptor signalling and prostate cancer. In 2010 she moved to Robert Kypta's group at Imperial College London (UK) as a postdoc. While maintaining her interest in prostate cancer, her project focused on Dickkopf-3 signalling. Diana joined the Nature Reviews Clinical Oncology team in July 2015, and became Chief Editor of the journal in September 2017.

Diana is based in the London office.

Senior Editor: David Killock, BSc, ARCS, PhD ORCiD

David obtained a BSc in Biochemistry from the Imperial College London. His undergraduate studies included a 1-year sandwich placement working in a GlaxoSmithKline drug metabolism and pharmacokinetics laboratory focused on metabolite identification. Subsequently, David became a Research Assistant working within the Membrane/Cytoskeletal Signalling Group of the National Heart and Lung Institute Cardiovascular Sciences Department, Imperial College London, and went on to conduct a PhD focused on mechanisms of leukocyte trafficking, under the guidance of Dr Aleksandar Ivetic. After moving with Dr Ivetic to King's College London Cardiovascular Division in 2009, David conducted a short post-doctoral project before moving out of the laboratory and into medical publishing as a Locum Associate Editor at Nature Reviews Rheumatology. Since joining Nature Reviews, he has worked on other titles, including Nature Reviews Urology. He joined the Nature Reviews Clinical Oncology team in 2014, where he was promoted to Senior Editor in 2016.

David is based in the London office.

Senior Editor: Peter Sidaway, BSc, PhD ORCiD

After studying pharmacology at the University of Newcastle Upon Tyne, UK, Peter commenced his doctoral studies in retinal neuroscience at the University of East Anglia, UK. After obtaining his PhD, he moved to the University of Birmingham, UK, where he became interested in autonomic neuroscience and neuropharmacology relating to the control of pelvic organ function. Peter further pursued these research interests as a Japan Society for the Promotion of Science overseas research fellow, before joining Nature Clinical Reviews as a Cross-Title Associate Editor in April 2014. He worked as an Associate Editor shared between Nature Reviews Urology and Nature Reviews Clinical Oncology. From November 2017, he is a Senior Editor for Nature Reviews Clinical Oncology.

Peter is based in the Berlin office.

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug